Next-generation sequencing in the lymphoid malignancies

Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy

Risk of breast cancer after chest radiotherapy may be affected by genetics

Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy

NY-ESO-1 immunotherapy for ovarian cancer

Imaging tumour habitats - life at the edge

Normal and neoplastic stem cells

WIN 2016: Preview of themes

WIN 2016: Preview of Speakers

Management of CLL patients in the front-line setting: live broadcast

Update on new agents in multiple myeloma – focus on monoclonal antibodies: an expert roundtable discussion

Novel agents before and after stem cell transplantation for myeloma